These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 210465)
21. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism. Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883 [TBL] [Abstract][Full Text] [Related]
22. Effect of repeated exposure to alcohol on the response of the hypothalamic-pituitary-adrenal axis of the rat: I. Role of changes in hypothalamic neuronal activity. Lee S; Schmidt ED; Tilders FJ; Rivier C Alcohol Clin Exp Res; 2001 Jan; 25(1):98-105. PubMed ID: 11198721 [TBL] [Abstract][Full Text] [Related]
23. Somatostatin precursors: evidence for presence in and release from rat median eminence and neurohypophysis. Zingg HH; Patel YC Biochem Biophys Res Commun; 1979 Sep; 90(2):466-72. PubMed ID: 508314 [No Abstract] [Full Text] [Related]
24. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action. Spinedi E; Giacomini M; Jacquier MC; Gaillard RC Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620 [TBL] [Abstract][Full Text] [Related]
25. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat. Blasquez C; Jégou S; Delarue C; Delbende C; Bunel DT; Braquet P; Vaudry H Eur J Pharmacol; 1990 Feb; 177(3):145-53. PubMed ID: 2155805 [TBL] [Abstract][Full Text] [Related]
26. Differential impact of predator or immobilization stressors on central corticotropin-releasing hormone and bombesin-like peptides in Fast and Slow seizing rat. Merali Z; Kent P; Michaud D; McIntyre D; Anisman H Brain Res; 2001 Jul; 906(1-2):60-73. PubMed ID: 11430862 [TBL] [Abstract][Full Text] [Related]
27. Vasopressin and CRF-ACTH in adrenalectomized and dexamethasone-treated rats. Hashimoto K; Yunoki S; Kageyama J; Ohno N; Takahara J; Ofuji T Neuroendocrinology; 1981 Feb; 32(2):87-91. PubMed ID: 6259547 [TBL] [Abstract][Full Text] [Related]
28. Effects of chronic maternal dexamethasone treatment on the hormones of the hypothalamo-pituitary-adrenal axis in the rat fetus. Dupouy JP; Chatelain A; Boudouresque F; Conte-Devolx B; Oliver C Biol Neonate; 1987; 52(4):216-22. PubMed ID: 2823915 [TBL] [Abstract][Full Text] [Related]
29. Changes in corticotrophin releasing factor of the stalk median eminence in rats with various cuts around the medial basal hypothalamus. Makara GB; Stark E; Rappay G; Kárteszi M; Palkovits M J Endocrinol; 1979 Nov; 83(2):165-73. PubMed ID: 316445 [TBL] [Abstract][Full Text] [Related]
30. Thyroxine modulates corticotropin-releasing factor but not arginine vasopressin gene expression in the hypothalamic paraventricular nucleus of the developing Rat. Dakine N; Oliver C; Grino M J Neuroendocrinol; 2000 Aug; 12(8):774-83. PubMed ID: 10929090 [TBL] [Abstract][Full Text] [Related]
31. Investigations on the nature of corticotrophin releasing factor using the perfused isolated rat anterior pituitary cell column [proceedings]. Gillies G; Estivariz FE; Lowry PJ J Endocrinol; 1979 Feb; 80(2):56P-57P. PubMed ID: 312311 [No Abstract] [Full Text] [Related]
32. Corticotrope response to removal of releasing factors and corticosteroids in vivo. Dallman MF; Makara GB; Roberts JL; Levin N; Blum M Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008 [TBL] [Abstract][Full Text] [Related]
33. Identification of an endocannabinoid system in the rat pars tuberalis-a possible interface in the hypothalamic-pituitary-adrenal system? Jafarpour A; Dehghani F; Korf HW Cell Tissue Res; 2017 Apr; 368(1):115-123. PubMed ID: 27999963 [TBL] [Abstract][Full Text] [Related]
34. Characterization and modulation of corticotropin-releasing factor in the neurointermediate pituitary gland. Jeandel L; Van Dorsselaer A; Lutz-Bucher B; Koch B Neuroendocrinology; 1987 Feb; 45(2):146-51. PubMed ID: 3033535 [TBL] [Abstract][Full Text] [Related]
35. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin. Kent P; Anisman H; Merali Z Neuroendocrinology; 2001 Mar; 73(3):203-14. PubMed ID: 11307039 [TBL] [Abstract][Full Text] [Related]
36. Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats. Buwalda B; de Boer SF; Schmidt ED; Felszeghy K; Nyakas C; Sgoifo A; Van der Vegt BJ; Tilders FJ; Bohus B; Koolhaas JM J Neuroendocrinol; 1999 Jul; 11(7):513-20. PubMed ID: 10444308 [TBL] [Abstract][Full Text] [Related]
37. Role of corticotropin-releasing hormone in gastrin-releasing peptide-mediated regulation of corticotropin and corticosterone secretion in male rats. Garrido MM; Martin S; Ambrosio E; Fuentes JA; Manzanares J Neuroendocrinology; 1998 Aug; 68(2):116-22. PubMed ID: 9705578 [TBL] [Abstract][Full Text] [Related]
38. Characterization of corticotropin releasing factor (CRF) and arginine vasopressin in median eminence extracts on sephadex gel-filtration. Hashimoto K; Ohno N; Yunoki S; Kageyama J; Aoki Y; Takahara J; Ofuji T Endocrinol Jpn; 1981 Feb; 28(1):1-7. PubMed ID: 6972867 [TBL] [Abstract][Full Text] [Related]
39. Studies on the tissue distribution and stability of "big" CRF (corticotropin-releasing factor). Yasuda N; Greer MA Life Sci; 1979 Feb; 24(6):549-56. PubMed ID: 34770 [No Abstract] [Full Text] [Related]
40. Cholecystokinin in the hypothalamo-hypophyseal system. Palkovits M; Kiss JZ; Beinfeld MC; Brownstein MJ Brain Res; 1984 May; 299(1):186-9. PubMed ID: 6722568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]